 | Up a level |
Cherney, David Z. and Dekkers, Claire C. J. and Barbour, Sean J. and Cattran, Daniel and Gafor, Abdul Halim Abdul and Greasley, Peter J. and Laverman, Gozewijn D. and Lim, Soo Kun and Di Tanna, Gian Luca and Reich, Heather N. and Vervloet, Marc G. and Wong, Muh Geot and Gansevoort, Ron T. and Heerspink, Hiddo J. L. and Investigators, DIAMOND (2020) Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial. Lancet Diabetes & Endocrinology, 8 (7). pp. 582-593. ISSN 2213-8587,
